
Learning Objectives:
- Comprehensive Understanding of Stroke Prevention in Atrial Fibrillation
- Navigating Antithrombotic Therapies for Stroke Prevention
- Translating Research into Practice for Enhanced Stroke Care
Scientific Program:
– Chair Introductions: Valeria Caso, Italy
– Burden of atrial fibrillation (AF) in stroke care: Cecilia Bahit, Argentina
– Antithrombotic Guidelines and unmet needs: Jan Scheitz, Germany
– Completed Phase II, and ongoing Phase III, Factor XI(a) inhibitor trials in AF or non-cardioembolic ischemic stroke: Ashkan Shoamanesh, Canada
– Q&A Discussion
Date & Time: September 19th, 3pm (CEST)
This webinar is supported by an unrestricted educational grant by Bayer AG.
Platinum Plus
Silver
Platinum Plus
Silver
Bronze
Bronze
Bronze
Corporate Supporters
Bronze
Bronze
Silver
Corporate Supporters
Bronze